HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thrombotic thrombocytopenia with von Willebrand factor deficiency induced by botrocetin. An animal model.

Abstract
Thrombotic thrombocytopenia with severe von Willebrand factor (vWF) depletion was induced in rats by intraperitoneal injection of botrocetin, a Bothrops factor requiring vWF for platelet aggregation. The vWF deficiency state with thrombocytopenia was produced in 12 animals by single or multiple injections of botrocetin. Single botrocetin injection (450 units/kg) reduced plasma vWF activity to less than 0.01 mu/ml for 24 hours and less than 0.2 units/ml up to 72 hours. During this period, multimeric analysis of plasma vWF:Ag revealed loss of intermediate and high molecular weight forms. A moderate reduction in vWF:Ag (Laurell) and FVIII:C was observed. Bleeding time remained prolonged during the deficiency state. Recovery of plasma vWF and platelet count occurred in 4 to 5 days. Multiple botrocetin injections (450 units/kg/injection) at 48-hour intervals produced a sustained severe vWF depletion (less than 0.2 units/ml) for 1 week. On the 8th day, vWF and platelet count had recovered to preinjection levels. Recovery was associated with the appearance of increased levels of very high molecular weight multimers of vWF:Ag in the plasma. After each botrocetin administration (single or repeat), a transient thrombocytopenia developed which was most severe at 1 to 5 hours postinjection. Another group of 10 animals was given a single botrocetin injection and specimens of lung, liver, kidney, and spleen were obtained at varying time intervals postinjection. Transmission electron micrographs of the lung and spleen 2 hours after botrocetin administration showed platelet aggregates and platelet microthrombi in the lung and spleen. The platelet thrombi in the lung had disappeared within 24 hours, and in the spleen by 48 hours. Liver sinusoids and kidney glomeruli were free of thrombi. A comparison is made of the thrombocytopenia and the ultrastructure of the platelet microthrombi induced by botrocetin with that of other agents.
AuthorsW E Sanders, M S Read, R L Reddick, J B Garris, K M Brinkhous
JournalLaboratory investigation; a journal of technical methods and pathology (Lab Invest) Vol. 59 Issue 4 Pg. 443-52 (Oct 1988) ISSN: 0023-6837 [Print] United States
PMID3262788 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Crotalid Venoms
  • Hemagglutinins
  • von Willebrand Factor
  • botrocetin
Topics
  • Animals
  • Blood Platelets (ultrastructure)
  • Crotalid Venoms
  • Densitometry
  • Disease Models, Animal
  • Electrophoresis, Polyacrylamide Gel
  • Female
  • Hemagglutinins
  • Hemolytic-Uremic Syndrome (etiology)
  • Immunoelectrophoresis, Two-Dimensional
  • Lung (pathology, ultrastructure)
  • Male
  • Microscopy, Electron
  • Platelet Count
  • Purpura, Thrombotic Thrombocytopenic (etiology, pathology)
  • Rats
  • Rats, Inbred Strains
  • Spleen (pathology, ultrastructure)
  • von Willebrand Factor (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: